Physician profile
Scott C Bemus
NPI 1891782272
$255.09
in general payments reported to CMS, 2019-2025
10 companies · $67.35 in 2025
The $67.35 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.16 · 2020: $11.80 · 2021: $14.61 · 2022: $16.05 · 2023: $98.02 · 2024: $33.10 · 2025: $67.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $52.46 | 2022-2023 | Acessa Provu System, Coolseal Generator |
| Biogen, INC. | $47.23 | 2025 | Zurzuvae |
| Abbvie INC. | $33.44 | 2023-2025 | Lo Loestrin Fe |
| Astellas Pharma US INC | $31.36 | 2023 | Veozah |
| Merck Sharp & Dohme LLC | $18.14 | 2024 | Gardasil 9, Gardasil |
| Exeltis, USA INC. | $16.93 | 2023 | Slynd |
| Vertex Pharmaceuticals Incorporated | $14.96 | 2024 | |
| Myovant Sciences INC. | $14.61 | 2021 | |
| Covidien LP | $14.16 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Bemus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.